Vitamin C and SARS coronavirus [6]

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 6, 2003, Pages 1049-1050

  Hemilä, Harri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Ascorbic acid; Pneumonia; Severe acute respiratory syndrome

Indexed keywords

ASCORBIC ACID; INTERFERON; PLACEBO;

CYTOKINE PRODUCTION; DRUG MECHANISM; EPIDEMIC; HUMAN; IMMUNE SYSTEM; INFECTION SENSITIVITY; LETTER; LYMPHOCYTE TRANSFORMATION; PHAGOCYTE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T LYMPHOCYTE;

ASCORBIC ACID; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0346888667     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh002     Document Type: Letter

References (6)

1. Holmes, K. V. (2003). SARS-associated coronavirus. New England Journal of Medicine 348, 1948-51.
2. Leibovitz, B. & Siegel, B. V. (1981). Ascorbic acid and the immune response. Advances in Experimental Medicine and Biology 135, 1-25.
3. Hemilä, H. & Douglas, R. M. (1999). Vitamin C and acute respiratory infections. International Journal of Tuberculosis and Lung Diseases 3, 756-61.
4. Atherton, J. G., Kratzing, C. C. & Fisher, A. (1978). The effect of ascorbic acid on infection of chick-embryo ciliated tracheal organ cultures by coronavirus. Archives of Virology 56, 195-9.
5. Davelaar, F. G. & Bos, J. (1992). Ascorbic acid and infectious bronchitis infections in broilers. Avian Pathology 21, 581-9.
6. Hemilä, H. (1997). Vitamin C intake and susceptibility to pneumonia. Pediatric Infectious Diseases Journal 16, 836-7.